Why were mRNA vaccines earlier available than conventional vaccines?
The mRNA that is the basis for the vaccines can be produced quickly and efficiently in a laboratory. It is also relatively easy to modify to create more effective or targeted vaccines. In contrast, the production of the recombinant proteins used in other types of vaccines is elaborate and time consuming.
Moreover, the manufacturers had already achieved promising results with mRNA vaccines in the spring of 2020. These results underscored the potential of the vaccines and inspired a certain market confidence. This increased the financial possibilities of companies for the development of the vaccines.
- What is an mRNA and what is its function?
- How do mRNA vaccines work?
- Which mRNA vaccines are approved or under development in Switzerland?
- Does the mRNA vaccine affect our genetic material?
- What do the approved mRNA vaccines contain?
- What side effects are known and expected for the approved mRNA vaccines?
- How effective are the approved mRNA vaccines?
- How and why are mRNAs modified for the vaccines?
- Is the technology behind the mRNA vaccines new?
- Why were mRNA vaccines earlier available than conventional vaccines?